Show Summary Details
Page of

Introduction: The growing innovation gap in life sciences 

Introduction: The growing innovation gap in life sciences
Introduction: The growing innovation gap in life sciences

Richard Barker

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 January 2021

We live in a world caught up in ever more rapid technological advance. Every week brings new IT products and services. Sectors as diverse as transport, energy, communications, and food are all bringing forward new ways to satisfy human need. However, biomedical innovation remains stubbornly slow and unproductive, as measured by output (benefit to patients) over input (investment). In fact, pharmaceutical innovation follows ‘Eroom’s Law’– an exponential decline in productivity that is the very reverse of Moore’s Law. This is despite very rapid progress in the underlying science. This ‘innovation gap’ puts at risk the very enterprise of life sciences, in which society and investors place so much faith. We need a scientific study of the gaps in translation and radical thinking to bridge them.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.